Instil Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a cell therapy pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. TIL therapies leverage... اقرأ أكثر
احصل على تحليلات مفصلة للأسهم من LSEG تتضمن السعر المستهدف بحسب رأي المحللين.